Advertisement

Opinion

Most Recent

image: Opinion: Sizing Up GM Salmon

Opinion: Sizing Up GM Salmon

By | June 1, 2014

On the potential benefits and risks of genetically modified fish entering the marketplace 

0 Comments

image: Opinion: Pairing Discovery with Regulatory Rigor

Opinion: Pairing Discovery with Regulatory Rigor

By | May 13, 2014

To move cell-based therapies into the clinic, academic researchers may benefit by consulting researchers outside of academia and the biopharma industry.

0 Comments

image: Opinion: Hone Your Craft, Sell Your Skills

Opinion: Hone Your Craft, Sell Your Skills

By | May 12, 2014

In an ever-changing job market, PhD scientists should be careful not to confuse their passion with their research foci, and to avoid academic tunnel vision.

0 Comments

image: Opinion: Latent Value in the Literature

Opinion: Latent Value in the Literature

By | April 28, 2014

With scientific budgets eroding, the biomedical community needs to get more return from the data it has already generated.

2 Comments

image: Opinion: The Pitfalls of Uncertainty

Opinion: The Pitfalls of Uncertainty

By | April 14, 2014

How to successfully inform policy when scientific evidence is not plainly evident.

2 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

image: Opinion: Measuring Impact

Opinion: Measuring Impact

By | February 24, 2014

Scientists must find a way to estimate the seemingly immeasurable impact of their research efforts.

3 Comments

image: Opinion: Beyond Partisanship in Biopolitics

Opinion: Beyond Partisanship in Biopolitics

By | February 18, 2014

Concerns about the relationship between science and society transcend traditional political differences.

0 Comments

image: Opinion: Translational Biotechnology

Opinion: Translational Biotechnology

By | February 17, 2014

Regulators must consider both the promise and potential pitfalls of new technologies when determining whether to move them into clinical trials.

0 Comments

image: Opinion: Reducing Whistleblower Risk

Opinion: Reducing Whistleblower Risk

By | February 11, 2014

It takes significant time and money for a scientist to defend his or her accusation of research misconduct.

5 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
The Scientist
The Scientist
Advertisement
The Scientist
The Scientist